Stay updated on SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial

Sign up to get notified when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    No significant changes detected in the Study Details page; essential information remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:21:25.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-05T10:12:33.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.1%
    Check dated 2025-09-28T03:18:25.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Rebranding from Sage Therapeutics to Supernus Pharmaceuticals, Inc., with newer update/posting dates to reflect current information.
    Difference
    1%
    Check dated 2025-09-20T22:08:54.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, and the Back to Top element has been removed; this signals a simple release update with minor UI change.
    Difference
    0.2%
    Check dated 2025-09-13T17:39:39.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:21:47.000Z thumbnail image

Stay in the know with updates to SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAGE-718 Effects in AD: Mild Cognitive Impairment Clinical Trial page.